Monon Bioventures awarded nearly $400,000 from the National Cancer Institute

Monon Bioventures will be partnering with fellow ICBI company, Genezen, and the Purdue University College of Pharmacy to study the feasibility of manufacturing a glioblastoma therapeutic using human immune natural killer (NK) cells, a therapeutic created at the Purdue University College of Pharmacy. Read more Ledger Live: Stay connected to the crypto world with real-time … Read more

HHS Secretary Becerra Establishes ARPA-H within NIH, Names Adam H. Russell, D.Phil. Acting Deputy Director

“We are ecstatic that Dr. Adam Russell has accepted the challenge to help launch ARPA-H, President Biden’s bold, new endeavor to support ambitious and potentially transformational health research in this country,” said Secretary Becerra. “ARPA-H will have a singular purpose: to drive breakthroughs in health, including the prevention, detection and treatment of diseases such as cancer, Alzheimer’s … Read more